• Main page
• About the journal
• Editorial board
• Subscription
• Information for contributors
• Editorial and Peer Review
• Issues archive
• Authors
• Articles
  • By alphabet
  • By category
• Blogs and comments

The journal is included into The list of leading scientific periodicals.

The journal is included into VINITI database and is registered in Electronic scientific library.

The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.

EBSCO

https://doi.org/10.14300/mnnc.2017.12114

Effect of HPV/Chlamydia trachomatis co -infection on the hormones level in intact ovarian tissue in cervical cancer

[Obstetrios and gynecology]
Elena Frantsiyants; Nailya Guskova; Tatyana Moiseenko; Marina Vovkochina; Natalia Cheryarina; Yulia Pogorelova;

Levels of sex hormones, steroid-binding protein and prolactin were studied by the solid-phase ELISA in intact ovarian tissues of 25 patients with cervical cancer (T1b-2aN0M0), mean age 53.4±3.2 y. o. depending on the presence of the HPV/Сh. tr. co-infection. Intact ovarian tissue without infection was obtained from 22 patients of similar age controls) during uterine extirpation for T1N0M0 endometrial cancer. HPV presence was detected by E7 protein expression, Ch. tr. – by IgG and IgА to Ch. tr. and antigen/DNA by the ELISA and PCR methods. Intact ovarian tissues of patients with cervical cancer were characterized by reduced levels of estradiol and progesterone and an increased estrone level, as well as by a high androgenic potential and a significant escalation of prolactin concentration. The data demonstrate that malignant process in the cervix on the background of HPV/Сh. tr. infection is accompanied by the hormonal profile imbalance in the tissue of the intact ovary. The results confirm the role of the infection as a trigger of the increased proliferation, malignancy in target organs for sex hormones.

Download

References:
1. Korolenkova L. I. Voprosy onkologii. – Problems in oncology. 2011;57(3):322-326.
2. Radzinskiy V. E., Solov’eva A. V. Tservikal’nyj skrining: klinicheskij protokol. Moscow, 2012.
3. Rogovskaya S. I., Lipova E. V. Fiziologiya, patologiya, kol’poskopiya, esteticheskaya korrektsiya: rukovodstvo dlya praktikuyushchikh vrachey. Moscow, 2014.
4. Sukhikh G. T., Solodkiy V. A., Ashrafyan L. A., Rozhkova N. I. Skrining i rannyaya diagnostika ginekologicheskogo raka. Moscow: «Molodaya gvardiya», 2011. P. 119-132.
5. Frantsiyants E. M., Bondovkina V. A., Gus’kova N. K., Komarova E. F. Fundamental’nye issledovaniya. – Fundamental research. 2013;7(2):419-422.
6. Bosch F. X., Broker T. R., Forman D., Moscicki A. B., Gillison M. L., Doorbar J., Stern P. L., Stanley M., Arbyn M., Poljak M., Cuzick J., Castle P. E., Schiller J. T., Markowitz L. E., Fisher W. A., Canfell K., Denny L. A., Franco E. L., Steben M., Kane M. A., Schiffman M., Meijer C. J., Sankaranarayanan R., Castellsagué X., Kim J. J., Brotons M., Alemany L., Albero G., Diaz M., de Sanjosé S. Vaccine. 2013;31(7):SH1-31. doi: 10.1016/j. vaccine.2013.07.026
7. Haggerty C. L., Gottlieb S. L., Taylor B. D., Low N., Xu F., Ness R. B. J. Infect. Dis. 2010;201(15):134-155. doi: 10.1086/652395
8. Hold G. L., El-Omar E. M. Biochemical J. 2008;410(2):225-235. doi: 10.1042/BJ20071341
9. Jemal A. F., Bray F., Centar M. M., Ferlay J., Ward E., Forman D. Cancer J. Clin. 2011;61(2):69-90. doi: 10.3322/caac.20107
10. Kurman R. J., Vang R., Junge J., Hannibal C. G., Kjaer S. K., Shih I.-M. Am. J. Surg. Pathol. 2011;35(11): 1605-1614. doi: 10.1097/PAS.0b013e318229449f
11. Lehtinen M., Ault K. A., Lyytikainen E., Dillner J., Garland S. M., Ferris D. G., Koutsky L. A., Sings H. L., Lu S., Haupt R. M., Paavonen J. Sex Transm. Infect. 2011;87(5):372-376. doi: 10.1136/ sti.2010.044354
12. Lin H.-W., Tu Y.-Y., Lin S. Y., Su W. J., Lin W. L., Lin W. Z., Wu S. C., Lai Y.L. Lancet Oncol. 2011;12(9):900-904. doi: 10.1016/S1470-2045(11)70165-6
13. Morin-Papunen L., Rantala A. S., Unkila-Kallio L., Tiitinen A., Hippeläinen M., Perheentupa A., Tinkanen H., Bloigu R., Puukka K., Ruokonen A., Tapanainen J. S. J. Clin. Endocrinol. Metab. 2012;97:1492-1500. doi: 10.1210/jc.2011-3061
14. Price M. J., Ades A. E., Soldan K., Welton N. J., Macleod J., Simms I., DeAngelis D., Turner K. M., Horner P. J. Health Technol. Assess. 2016;20(22):1-250. doi: 10.3310/ hta20220
15. Rasmussen C. B., Faber M. T., Jensen A., Hogdall E., Hogdall C., Blaakær J, Kjaer S. K. Cancer Causes Control. 2013;24(7):1459-1464. doi: 10.1007/s10552- 013-0216-y
16. Rinaldi S., Plummer M., Biessy C., Castellsague X., Overvad K., Krueger K., Tjonneland A., Clavel-Chapelon F., Chabbert-Buffet N., Mesrine S., Lukanova A., Kaaks R., Weikert C., Boeing H., Trichopoulou A., Lagiou P., Trichopoulos D., Palli D., Agnoli C., Tumino R., Vineis P., Panico S., Bueno-de-Mesquita B., van Kranen H. J., Peeters P. H. M., Bakken K., Lund E., Gram I. T., Rodriguez L., Bosch F. X., Sanchez M., Dorronsoro M., Navarro C., Gurrea A. B., Kjellberg L., Dillner J., Manjer J., Butt S., Khaw K., Wareham N., Allen N. E., Travis R., Romieu I., Ferrari P., Riboli E., Franceschi S. Cancer Epidemiol. Biomarkers Prev. 2011;20: 2532-2540. doi: 10.1158/1055-9965.EPI-11-0753
17. Roura E. E., Travier N., Waterboer T., de Sanjosé S., Bosch F. X., Pawlita M., Pala V., Weiderpass E., Margall N., Dillner J., Gram I. T., Tjonneland A., Munk C., Palli D., Khaw K., Overvad K., Clavel-Chapelon F., Mesrine S., Fournier A., Fortner R. T., Ose J., Steffen A., Trichopoulou A., Lagiou P., Orfanos P., Masala G., Tumino R., Sacerdote C., Polidoro S., Mattiello A., Lund E., Peeters P. H., Bueno-de-Mesquita H. B., Quiros J. R., Sanchez M. J., Navarro C., Barricarte A., Larranaga N., Ekstrom J., Lindquist D., Idahl A., Travis R. C., Merritt M. A., Gunter M. J., Rinaldi S., Tommasino M., Franceschi S., Riboli E., Castellsague X. PLoS One. 2016;11(1):e0147029. doi: 10.1371/journal. pone.0147029
18. Shew M. L., Fortenberry J. D., Tu W., Juliar B. E., Batteiger B. E., Qadadri B., Brown D. R. Arch. Pediatr. Adolesc Med. 2006;160(2):151-156. doi: 10.1001/ archpedi.160.2.151
19. Yoo Y. A., Son J., Mehta F. F., DeMayo F. J., Lydon J. P., Chung S.H. Am. J. Pathol. 2013;183:1679-1687. doi: 10.1016/j.ajpath.2013.07.026

Keywords: cervical cancer, intact ovarian tissue, hormonal profile, HPV, Chlamydia trachomatis